Julie Bruneau Selected Research

Julie Bruneau Research Topics

Disease

64	Infections 10/2021 - 11/2002
23	Hepatitis C 10/2021 - 04/2007
11	HIV Infections (HIV Infection) 12/2019 - 07/2008
8	Opioid-Related Disorders (Opiate Addiction) 10/2022 - 01/2003
7	Acquired Immunodeficiency Syndrome (AIDS) 12/2019 - 07/2008
6	Reinfection 01/2021 - 10/2014
5	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2021 - 01/2017
5	Persistent Infection 01/2021 - 06/2007
5	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 03/2015
4	Substance-Related Disorders (Drug Abuse) 09/2022 - 01/2018
4	Blister (Bulla) 10/2020 - 01/2018
4	Mood Disorders (Mood Disorder) 03/2018 - 06/2005
4	Neoplasms (Cancer) 08/2017 - 04/2015
4	Communicable Diseases (Infectious Diseases) 01/2017 - 08/2004
4	Virus Diseases (Viral Diseases) 01/2017 - 04/2010
3	Pain (Aches) 11/2020 - 04/2007
3	Anxiety Disorders (Anxiety Disorder) 03/2018 - 10/2015
3	Mental Disorders (Mental Disorder) 03/2018 - 01/2016
3	Fibrosis (Cirrhosis) 01/2018 - 10/2016
3	Drug Overdose 01/2017 - 08/2004
3	Mastocytosis 01/2014 - 05/2013
2	Opiate Overdose 10/2022 - 10/2019
2	Leukemia 01/2021 - 01/2020
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2021 - 08/2017
2	Wounds and Injuries (Trauma) 10/2019 - 01/2016
2	Chronic Hepatitis C 01/2017 - 06/2013
2	Lymphopenia (Lymphocytopenia) 01/2016 - 01/2012
2	HIV Seropositivity 05/2011 - 08/2005
2	Viremia 03/2010 - 06/2007
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Ulcer 06/2021
1	Human Influenza (Influenza) 01/2021
1	COVID-19 01/2021
1	Yellow Fever 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Candidiasis (Moniliasis) 11/2020
1	Subcutaneous panniculitis-like T-cell lymphoma 01/2020
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2020
1	Enterocolitis 01/2019
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2019

Drug/Important Bio-Agent (IBA)

26	Pharmaceutical PreparationsIBA 10/2022 - 08/2004
19	Opioid Analgesics (Opioids)IBA 10/2022 - 06/2005
14	Antiviral Agents (Antivirals)IBA 10/2021 - 06/2007
13	Cocaine (Cocaine HCl)IBA 09/2022 - 01/2003
11	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2007
10	InterferonsIBA 01/2020 - 10/2008
9	Methadone (Dolophine)FDA LinkGeneric 10/2022 - 01/2003
9	LigandsIBA 01/2022 - 02/2010
6	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 01/2017
6	Biological ProductsIBA 01/2019 - 10/2013
5	Naloxone Drug Combination Buprenorphine FDA Link 10/2022 - 01/2018
5	KIR ReceptorsIBA 12/2019 - 03/2008
5	CytokinesIBA 06/2013 - 06/2007
4	SofosbuvirIBA 10/2021 - 01/2018
4	velpatasvirIBA 10/2021 - 01/2018
4	Interleukin-10 (Interleukin 10)IBA 01/2021 - 04/2010
4	Buprenorphine (Subutex)FDA LinkGeneric 12/2020 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2005
3	EpitopesIBA 01/2021 - 10/2014
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 12/2016
3	Heroin (Diamorphine)IBA 01/2021 - 01/2003
3	Illicit Drugs (Recreational Drugs)IBA 11/2020 - 08/2004
3	VaccinesIBA 12/2019 - 01/2015
3	HLA-B Antigens (HLA-B)IBA 10/2016 - 07/2008
3	Interferon LambdaIBA 09/2016 - 11/2014
2	interleukin-21 (interleukin 21)IBA 01/2021 - 01/2013
2	AntigensIBA 01/2021 - 01/2018
2	dasabuvirIBA 10/2020 - 12/2018
2	Ritonavir (Norvir)FDA Link 10/2020 - 12/2018
2	ombitasvirIBA 10/2020 - 12/2018
2	paritaprevirIBA 10/2020 - 12/2018
2	ParaffinIBA 01/2019 - 01/2019
2	5-hydroxymethylcytosineIBA 01/2018 - 08/2017
2	Azacitidine (5 Azacytidine)FDA Link 12/2017 - 03/2015
2	Interferon-alpha (Interferon Alfa)IBA 01/2017 - 01/2012
2	Natural Killer Cell ReceptorsIBA 10/2016 - 07/2008
2	Interleukin-2 (IL2)IBA 01/2016 - 03/2010
2	HLA-B57 antigenIBA 01/2014 - 07/2008
2	Interleukin-10 ReceptorsIBA 11/2013 - 04/2010
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2022
1	CannabidiolIBA 09/2022
1	AntibodiesIBA 06/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Brentuximab VedotinIBA 01/2020
1	HLA-A Antigens (HLA-A)IBA 12/2019
1	Rho Guanine Nucleotide Exchange FactorsIBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019

Therapy/Procedure

27	Therapeutics 10/2022 - 10/2008
7	Opiate Substitution Treatment 01/2018 - 10/2012
3	Transplantation 06/2021 - 04/2015
3	Drug Therapy (Chemotherapy) 12/2017 - 12/2014
2	Ligation 01/2022 - 01/2020
2	Hematopoietic Stem Cell Transplantation 01/2020 - 12/2014
1	Pain Management 11/2020
1	Retreatment 01/2020